3 The pharmacokinetic feasibility gate: exposure, half-life, and the accumulation requirement The central determinant of whether an orally administered peptide achieves therapeutic systemic exposure is not the sophistication of the delivery platform, but the relationship among absorption rate, elimination half-life, and dosing interval
Patients appreciate the depth of testing, the precision of treatment, and the supportive environment that empowers them to take control of their health
Aldosari BN, Abd El-Aal M, Abo Zeid EF, Faris TM, Aboelela A, Abdellatif AA, Tawfeek HM (2023) Synthesis and characterization of magnetic AgFe3O4@ polymer hybrid nanocomposite systems with promising antibacterial application
In senescent cells, the transcription factor FOXO4 binds to p53 (the tumor suppressor "guardian of the genome"), sequestering p53 away from mitochondria where it would trigger apoptosis
10.1152/physrev.00005.2018 51 HasenfussG.ReineckeH.StuderR.MeyerM.PieskeB.HoltzJ.et al (1994)
Hwa, who was not part of the Triological panel but co-authored a Bulletin on the evaluation and management of PT for the American Academy of OtolaryngologyHead and Neck Surgery (AAO-HNS